Bianca L. Artiaga

Bianca L. Artiaga

Auto-generated profile, based on publicly available information

Bianca L. Artiaga

Department of Animal Science, University of Florida, Gainesville, FL, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2016 in Scientific Reports
Verified
Journal Article
Open access
BABianca L. Artiaga
Bianca L. Artiaga
GYGuan Yang
Guan Yang
THTimothy J. Hackmann
Timothy J. Hackmann
QLQinfang Liu
Qinfang Liu
JRJürgen A. Richt
Jürgen A. Richt
JDJohn Driver
John Driver
Natural killer T (NKT) -cells activated with the glycolipid ligand α-galactosylceramide (α-GalCer) stimulate a wide array of immune responses with many promising immunotherapeutic applications, including the enhancement of vaccines against infectious diseases and cancer. In the current study, we evaluated whether α-GalCer generates protective immunity against a swine influenza (SI) virus infection when applied as an intramuscular vaccine adjuvant. Immunization of newly weaned piglets with UV-killed pandemic H1N1 A/California/04/2009 (kCA04) SI virus and α-GalCer induced high titers of anti-hemagglutinin antibodies and generated virus-specific T cells that localized in intrapulmonary airways and in alveolar walls. Vaccination with α-GalCer resulted in a systemic increase in NKT-cell concentrations, including in the respiratory tract, which was associated with complete inhibition of viral replication in the upper and lower respiratory tract and much reduced viral shedding. These results indicate that NKT-cell agonists could be used to improve swine vaccine formulations in order to reduce the clinical signs of SI infection and limit the spread of influenza viruses amongst commercial pigs.

1 November 2014 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
BABianca L. Artiaga
Bianca L. Artiaga
RWRobert L. Whitener
Robert L. Whitener
CSCharles R. Staples
Charles R. Staples
JDJohn Driver
John Driver

29 November 2016 in Scientific Reports
Verified
Journal Article
Open access
BABianca L. Artiaga
Bianca L. Artiaga
GYGuan Yang
Guan Yang
THTarun E. Hutchinson
Tarun E. Hutchinson
JLJulia C. Loeb
Julia C. Loeb
JRJürgen A. Richt
Jürgen A. Richt
JDJohn Driver
John Driver
Swine influenza A viruses (IAV) are a major cause of respiratory disease in pigs and humans. Currently approved anti-influenza therapies directly target the virus, but these approaches are losing effectiveness as new viral strains quickly develop drug resistance. To over come this challenge, there is an urgent need for more effective antiviral drugs. Here we tested the anti-influenza efficacy of the invariant natural killer T (NKT) cell superagonist, α-galactosylceramide (α-GalCer), which stimulates a wide array of anti-viral immune responses. We show that intranasal but not systemic administration of α-GalCer to piglets infected with pandemic A/California/04/2009 (CA04) H1N1 IAV ameliorated disease symptoms and resulted in the restoration of weight gain to the level of uninfected pigs. Correspondingly, viral titers in the upper-and lower-respiratory tract were reduced only in piglets that had received intranasal α-GalCer. Most significantly, lung inflammation as a consequence of virus persistence was largely prevented when NKT-cells were targeted via the respiratory route. Thus, targeting mucosal NKT-cells may provide a novel and potent platform for improving the course of disease in swine infected with seasonal and pandemic influenza viruses, and leads to the suggestion that this may also be true in humans and therefore deserves further study.

1 May 2015 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
GYGuan Yang
Guan Yang
BABianca L. Artiaga
Bianca L. Artiaga
THTimothy J. Hackmann
Timothy J. Hackmann
MSMelissa S. Samuel
Melissa S. Samuel
EWEric M. Walters
Eric M. Walters
JDJohn Driver
John Driver

1 November 2017 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
GYGuan Yang
Guan Yang
BABianca L. Artiaga
Bianca L. Artiaga
SLSarah T. Lewis
Sarah T. Lewis
JDJohn Driver
John Driver